|
gptkbp:instance_of
|
gptkb:pharmaceuticals
|
|
gptkbp:accessories
|
with raw material suppliers
|
|
gptkbp:acquired_by
|
gptkb:pharmaceuticals
|
|
gptkbp:acquisition
|
Teva Pharmaceutical Industries in 2010
|
|
gptkbp:benefits
|
competitive packages
|
|
gptkbp:brand
|
strong among consumers
|
|
gptkbp:brand_recognition
|
high in Europe
|
|
gptkbp:business_model
|
commitment to integrity
generic drug production
|
|
gptkbp:categories
|
OTC and prescription drugs
|
|
gptkbp:certification
|
GMP certified
|
|
gptkbp:clinical_trial
|
collaborates with universities
conducts regularly
|
|
gptkbp:community_engagement
|
healthcare education programs
|
|
gptkbp:community_support
|
local health initiatives
|
|
gptkbp:customer_base
|
healthcare providers
|
|
gptkbp:customer_satisfaction
|
high ratings
|
|
gptkbp:distribution
|
pharmacies
across Europe
|
|
gptkbp:distribution_channels
|
pharmaceutical wholesalers
|
|
gptkbp:economic_development
|
consistent over years
|
|
gptkbp:economic_impact
|
ongoing efforts
|
|
gptkbp:employees
|
over 1,000
approximately 1,500
|
|
gptkbp:financial_performance
|
strong growth
|
|
gptkbp:financial_reports
|
published annually
|
|
gptkbp:financial_stability
|
solid performance
|
|
gptkbp:founded
|
gptkb:1963
|
|
gptkbp:founder
|
gptkb:Wolfgang_W._Ratiopharm
Heinrich D. Schulte
|
|
gptkbp:global_presence
|
operates in multiple countries
|
|
gptkbp:governance
|
transparent practices
|
|
gptkbp:headquarters
|
gptkb:Ulm,_Germany
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Ratiopharm
|
|
gptkbp:industry
|
gptkb:pharmaceuticals
|
|
gptkbp:innovation
|
continuous improvement
focus on new formulations
|
|
gptkbp:invention
|
numerous pharmaceutical patents
|
|
gptkbp:investment
|
in technology and innovation
active communication
|
|
gptkbp:key_people
|
gptkb:Dr._H._D._Schulte
|
|
gptkbp:location
|
gptkb:Germany
|
|
gptkbp:market
|
gptkb:Europe
conducts regularly
|
|
gptkbp:market_launch
|
frequent new offerings
|
|
gptkbp:market_position
|
leading generic manufacturer
|
|
gptkbp:market_share
|
significant in Germany
|
|
gptkbp:marketing_strategy
|
targeted campaigns
|
|
gptkbp:parent_company
|
gptkb:pharmaceuticals
|
|
gptkbp:partnerships
|
various healthcare organizations
with research institutions
|
|
gptkbp:product_line
|
over 1,000 products
|
|
gptkbp:product_quality
|
high standards
|
|
gptkbp:products
|
generic drugs
|
|
gptkbp:regulatory_compliance
|
strict adherence
dedicated team
|
|
gptkbp:research_and_development
|
strong focus
|
|
gptkbp:revenue
|
€1 billion (approx.)
|
|
gptkbp:safety
|
prioritized in development
|
|
gptkbp:side_effect
|
significant in Europe
|
|
gptkbp:social_responsibility
|
active engagement
active in community health
|
|
gptkbp:specialization
|
generic pharmaceuticals
|
|
gptkbp:subsidiary
|
gptkb:Ratiopharm_Gmb_H
|
|
gptkbp:supply_chain
|
efficient logistics
optimized processes
|
|
gptkbp:sustainability_initiatives
|
environmental responsibility
|
|
gptkbp:training
|
ongoing development programs
|
|
gptkbp:trends
|
adapts to changes
|
|
gptkbp:type
|
private company
|
|
gptkbp:website
|
www.ratiopharm.de
|
|
gptkbp:bfsParent
|
gptkb:Teva
|
|
gptkbp:bfsLayer
|
4
|